Venture-Backed Dermatology Co. Files $75M IPO
Sienna Biopharmaceuticals Inc., a venture-backed company developing dermatology products to treat psoriasis and related ailments, filed a $75 million initial public offering Monday advised by Latham & Watkins LLP, marking the...To view the full article, register now.
Already a subscriber? Click here to view full article